Bexarotene combined with lapatinib for the treatment of Cushing's disease: evidence based on drug repositioning and experimental confirmation

SIGNAL TRANSDUCTION AND TARGETED THERAPY

NATURE PUBLISHING GROUP

1. National Natural Science Foundation of China [81670456]
2. Drug Innovation Major Project of China [2018ZX09711001-003-001]
3. Natural Science Foundation of Beijing Municipality (CN) [7162132]
4. CAMS Innovation Fund for Medical Sciences [2017-I2M-1-011]